Oriola-KD makes changes to management team

Henry Fogels adds acting director general of wholesale business in Russia to his duties

Henry Fogels, general director of Oriola-KD's Pharmaceutical Retail business in Russia (OOO Vitim) has been nominated, in addition to his current duties, to the position of acting general director of Oriola-KD's Pharmaceutical Wholesale business in Russia.

Fogels will continue as a member of Oriola-KD's Group Management Team, being responsible for Oriola-KD's businesses in Russia.

Fogels has replaced Vladimir Knyazev, who left the Espoo, Finland-based company this month.

You may also like

Manufacturing

Oriola-KD to sell healthcare trade business to Mediq

Dutch firm to acquire Oriola-KD businesses across Scandinavia and Europe
Marketing

Guardtech Group welcome new ‘cleanroom chameleon’ mascot into the mix to celebrate company’s role as enablers of change

Cammi the Chameleon will be appearing across the East Anglian cleanroom construction specialists’ marketing throughout 2026 to represent Guardtech’s aim to support groundbreaking developments in Life Sciences and beyond
Drug Delivery

SCHOTT Pharma and SHL Medical pre-validate polymer cartridge platform for large-volume autoinjectors

SCHOTT Pharma has pre-validated its ISO-standardised TOPPAC polymer cartridge for compatibility with SHL Medical’s large-volume Maggie autoinjector platform. The collaboration delivers a de-risked, ready-to-use solution for the safe at-home administration of large-volume therapies
Microbiology

Ingenza debuts Bacillus protein production system alternative to E. coli

The Scottish CRDMO's new GenXpress Bacillus technology offers a highly productive alternative to the traditional E. coli expression systems that is free from endotoxins and antibiotic resistance markers
Sustainability

BioDuro sites recognised with EcoVadis Gold and Silver sustainability certifications

Three of the CDMO's Chinese sites have been recognised for outstanding sustainability performance, highlighting BioDuro’s commitment to sustainability and its ongoing efforts to embed environmental and social responsibility into its business operations
Manufacturing

IMA Life-Sharp Sterile Manufacturing partnership strengthened with aseptic technology facility

Sharp's expanded facility in Massachusetts will include the installation of a fully automated IMA Life isolated filling line for Ready-To-Use (RTU) vials, addressing demand for US-based aseptic fill-finish services
Manufacturing

Cellistic launches three new iPSC-based GMP platforms to advance immuno-oncology and regenerative therapies

The three new iPSC-derived GMP manufacturing platforms, Echo-T, Echo-Cardio and Echo-Endothelial, expand the company’s Echo portfolio and are designed to improve scalability and manufacturability across immuno-oncology and regenerative medicine programmes
Subscribe now